USFDA inspection at Rubicon Research Ltd's R&D Facility

The United States Food and Drug Administration (USFDA) conducted an unannounced inspection at Rubicon Research Limited's R&D facility located at Concord, Ontario, Canada, from April 20, 2026 to April 24, 2026.

The inspection concluded without any Form-483 being issued.

We remain committed to maintaining the highest standards of compliance and quality.

Shares of Rubicon Research Limited was last trading in BSE at Rs. 938.65 as compared to the previous close of Rs. 927.75. The total number of shares traded during the day was 26854 in over 3040 trades.

The stock hit an intraday high of Rs. 943.90 and intraday low of 920.00. The net turnover during the day was Rs. 25140842.00.

Source : Equity Bulls

Keywords

RubiconResearch INE506V01022 Pharmaceuticals USFDA Inspection RandFacility Concord Ontario Canada